ChemInform Abstract: The First Synthesis of Diethyl α,α‐Chlorofluorobenzylphosphonates.

In order to translate nanotechnology into medical practice, magnetic nanoparticles (MNPs) have been presented as a class of non‐invasive nanomaterials for numerous biomedical applications. In particular, MNPs have opened a door for simultaneous diagnosis and brisk treatment of diseases in the form of theranostic agents. This review highlights the recent advances in preparation and utilization of MNPs from the synthesis and functionalization steps to the final design consideration in evading the body immune system for therapeutic and diagnostic applications with addressing the most recent examples of the literature in each section. This study provides a conceptual framework of a wide range of synthetic routes classified mainly as wet chemistry, state‐of‐the‐art microfluidic reactors, and biogenic routes, along with the most popular coating materials to stabilize resultant MNPs. Additionally, key aspects of prolonging the half‐life of MNPs via overcoming the sequential biological barriers are covered through unraveling the biophysical interactions at the bio–nano interface and giving a set of criteria to efficiently modulate MNPs' physicochemical properties. Furthermore, concepts of passive and active targeting for successful cell internalization, by respectively exploiting the unique properties of cancers and novel targeting ligands are described in detail. Finally, this study extensively covers the recent developments in magnetic drug targeting and hyperthermia as therapeutic applications of MNPs. In addition, multi‐modal imaging via fusion of magnetic resonance imaging, and also innovative magnetic particle imaging with other imaging techniques for early diagnosis of diseases are extensively provided.

show abstract

“…Furthermore, subsequent treatments are required for protecting the environment from the generated wastewaters with very basic pH values. [78] …”

Section: Coprecipitationmentioning

confidence: 99%

Synthesis, Functionalization, and Design of Magnetic Nanoparticles for Theranostic Applications

Mosayebi

Kiyasatfar

Laurent

2017

Adv Healthcare Materials

192

171

View full text Add to dashboard Cite

show abstract

“…27 Therefore, their protection and the coating of the naked MNPs with organic or inorganic layers is a valuable strategy which also provides useful sites for further functionalization of the material. 28,29 Considering the less costs with much higher purity of Cu(II) salts in comparison with the corresponding Cu(I) salts, herein we report preparation of a novel and a magnetically recoverable Cu(OAc) 2 /2-aminobenzenthiol complex immobilized on magnetite/silica nanoparticles (Fe 3 O 4 /SiO 2 NPs). This magnetic composite has been successfully used as a catalyst for the synthesis of 1,2,3-triazole derivatives via a three-component condensation of terminal alkynes, benzyl or alkyl halides, in the presence of sodium azide under mild conditions.…”

Section: Introductionmentioning

confidence: 99%

A copper acetate/2-aminobenzenthiol complex supported on magnetite/silica nanoparticles as a highly active and recyclable catalyst for 1,2,3-triazole synthesis

2015

View full text Add to dashboard Cite

show abstract

ChemInform Abstract: The First Synthesis of Diethyl α,α‐Chlorofluorobenzylphosphonates.

Abstract: Organo-phosphorus compounds S 0080The First Synthesis of Diethyl α,α-Chlorofluorobenzylphosphonates. -The title compounds (III) are prepared from α-hydroxyphosphonates by chlorination followed by fluorination. -(WU, D.; HE, Y.; TANG, R.; GUAN*

Cited by 2 publications

References 1 publication

Synthesis, Functionalization, and Design of Magnetic Nanoparticles for Theranostic Applications

Synthesis, Functionalization, and Design of Magnetic Nanoparticles for Theranostic Applications

A copper acetate/2-aminobenzenthiol complex supported on magnetite/silica nanoparticles as a highly active and recyclable catalyst for 1,2,3-triazole synthesis

Contact Info

Product

Resources

About